首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical and experimental ophthalmology

缩写:CLIN EXP OPHTHALMOL

ISSN:1442-6404

e-ISSN:1442-9071

IF/分区:5.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3213
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mostafa Bondok,Leonardo Lando,Anne Xuan-Lan Nguyen et al. Mostafa Bondok et al.
Background: To assess financial disclosures of American ophthalmology society board members by comparing self-reported disclosures with industry-reported payments and examining characteristics linked to larger financial r...
Ye Li,Lauren N Ayton,Adrian T Fung Ye Li
Geographic atrophy (GA) causes significant vision impairment and reduction in vision-related quality of life. Fundus autofluorescence (FAF) is the gold standard of structural assessment of GA but is a surrogate marker for vision loss, which...
Li Yen Chan,Ye Li,Shuan Dai Li Yen Chan
Background: Intraocular lens implantation in children with insufficient zonular support can be challenging. Scleral-fixated intraocular lens (SFIOL) implantation can be useful in these cases. We aim to report the visual a...
Vivien Nguyen,Santosh Khanal,Graham Wilson et al. Vivien Nguyen et al.
Background: The University of Sydney 'Microsurgical Skills Course' (MSC) was made mandatory to the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Vocational Training Program in 2023. This study eval...
Olivia Rolfe,James Elder,John McKenzie et al. Olivia Rolfe et al.
Background: The objective of this study was to compare the burden of treatment of different primary treatment modalities for unilateral sporadic retinoblastoma. ...
Trung M Dang,Alessandro Invernizzi,Vuong Nguyen et al. Trung M Dang et al.
Background: We analysed 12-month real-world outcomes of treatment of eyes with neovascular age-related macular degeneration switched to brolucizumab from a first-generation VEGF inhibitor to determine whether switching ch...